An anti-inflammatory melanocortin fusion polypeptide augments whole blood resuscitation of hemorrhagic shock in a rodent polytrauma model
Authors:
- Jung Heon KimJKJung Heon Kim
- Lauren E. NeidigLNLauren E. Neidig
- Kristyn M. RinggoldKRKristyn M. Ringgold
- Chang Yeop HanCHChang Yeop Han
- Kathryn I. DeYoungKDKathryn I. DeYoung
- Alexander E. St. JohnAJAlexander E. St. John
- Xu WangXWXu Wang
- Ronald BerensonRBRonald Berenson
- Susan A. SternSSSusan A. Stern
- Nathan J. WhiteNWNathan J. White
- 27 October 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
Abstract
BACKGROUND: Severe trauma induces a cytokine storm that is associated with impaired resuscitation and recovery. We investigated the impact of AQB-565, an anti-inflammatory melanocortin fusion polypeptide, as a novel treatment adjunct for whole blood resuscitation of hemorrhagic shock using a rat polytrauma shock model. METHODS: Hemorrhagic shock with polytrauma was induced in 64 Sprague-Dawley rats. The rats were randomized to receive one of four intravenous treatments at 15 minutes posthemorrhage (T15): saline control, AQB-565, tranexamic acid (TXA), or combined AQB-565+ TXA. The rats were given autologous transfusion of shed whole blood at 60 minutes and as needed thereafter to achieve mean arterial pressure (MAP) of 60 mm Hg for up to 3 hours. Survival, hemodynamics, cytokine profiles, and hemorrhage volumes were compared between groups. RESULTS: There was a significant overall effect of treatment group on MAP (two-way rmANOVA p =0.02) that coincided with blood transfusion. MAP was significantly increased at T105 with AQB-565+TXA versus saline control ( p =0.046). Inflammatory plasma cytokines, including interleukin-6, were significantly decreased with AQB-565 versus control groups (ANOVA p values ≤ 0.01). Seventeen (26.6%) rats died before 3 hours. There was a trend towards increased survival for treatments containing AQB-565 versus controls that was not statistically significant (Kaplan-Meier log rank p =0.06). CONCLUSIONS: A melanocortin pathway-activating polypeptide suppressed inflammation and improved hemodynamic response to whole blood transfusion in this hemorrhagic shock model.Keywords
This publication has 36 references indexed in Scilit:
- Massive Hemorrhage ProtocolEmergency Medicine Clinics of North America, 2022
- The multifaceted role of plasminogen in inflammationCellular Signalling, 2020
- AQB-565 shows promise in preclinical testing in the model of epileptic spasms during infancy: Head-to-head comparison with ACTHEpilepsy Research, 2019
- ACTH as first line treatment for acute gout in 181 hospitalized patientsJoint Bone Spine, 2013
- Structure, function and regulation of the melanocortin receptorsEuropean Journal of Pharmacology, 2011
- Hemorrhagic Shock-Induced Vascular Hyporeactivity in the Rat: Relationship to Gene Expression of Nitric Oxide Synthase, Endothelin-1, and Select Cytokines in Corresponding OrgansJournal of Surgical Research, 2005
- Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathwayCardiovascular Research, 2004
- New aspects on the melanocortins and their receptorsPharmacological Research, 2000
- Characterisation of melanocortin receptor subtypes by radioligand binding analysisEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Effect of ACTH-(1-24) on the volume of circulating blood and on regional blood flow in rats bled to hypovolemic shockResuscitation, 1989